Chengdu Huasun’s Recombinant Human Epidermal Growth Factor Cleared
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA approved Chengdu Huasun Bio-technology Co. Ltd.’s recombinant human epidermal growth factor medicine.